Yıl: 2022 Cilt: 11 Sayı: 3 Sayfa Aralığı: 1158 - 1165 Metin Dili: İngilizce DOI: 10.5455/medscience.2021.11.383 İndeks Tarihi: 12-10-2022

Evaluation of epicardial adipose tissue thickness and inflammatory parameters in smokers and non-smokers

Öz:
Smoking is the leading cause of preventable death. Epicardial adipose tissue (EAT) surrounds the heart surface and creates local and systemic effects secreting the hormones, cytokines, inflammatory mediators. Previous studies demonstrated that both smoking and EAT have a strong association with inflammation and atherosclerosis.Our study aimed to determine the relationship of smoking with EAT thickness and inflammation by evaluating smokers and non-smokers. A total of 259 healthy male and female participants between the ages of 18-65, without a history of chronic disease and with a body mass index within normal limits, were included in a study. EAT thickness measurements were made by transthoracic echocardiography and EAT thicknesses of smokers and non-smokers were compared. In addition, the effects of smoking and EAT thickness on different inflammatory parameters were evaluated. When the EAT thicknesses were compared between smokers and non-smokers (2.60±1.2), a statistically significant difference was found in favor of smokers (3.84±1.84) (p<0.001). A moderate positive correlation was found among age, body mass index, smoking duration in years, pack/year and EAT thickness. The difference among waist circumference, the number of cigarettes smoked daily, diastolic blood pressure, fasting blood glucose, ALT, AST, total cholesterol, triglyceride, LDL-cholesterol, CRP, uric acid, platelet count, MPV values, platelet/lymphocyte ratio and EAT thickness were found meaningful, but the weak correlation in different ratios were determined. Smoking was found to be the most important determinant of EAT thickness. Other determinants of EAT thickness were age, body mass index, CRP and female gender. The significant statistical relationship between smoking and EAT thickness suggests that smoking increases EAT thickness and inflammatory parameters. Co-assessment of the EAT and blood inflammatory parameters in smokers may guide the initiation of medical treatment in primary prevention or other therapies.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol. 2004;43:1731-7.
  • Rodgman A, TA Perfetti. "Tobacco and/or tobacco smoke components used as tobacco ingredients." The Chemical Components Tobacco Smoke. 2013;1221-301.
  • WHO. "World Health Organization. WHO report on the global tobacco epidemic." 2011: Warning about the dangers of tobacco (2011).
  • Monti M, Monti A, Murdolo G, et al. Correlation between epicardial fat and cigarette smoking: CT imaging in patients with metabolic syndrome. Scand Cardiovasc J. 2014;48:317-22.
  • Eiras S, Teijeira-Fernandez E, Shamagian LG, et al. Extension of coronary artery disease is associated with increased IL-6 and decreased adiponectin gene expression in epicardial adipose tissue. Cytokine. 2008;43:174-80.
  • Iacobellis G, Pistilli D, Gucciardo M, et al. Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease. Cytokine. 2005;29:251-5.
  • Nagy E, Jermendy AL, Merkely B, et al. Clinical importance of epicardial adipose tissue. Arch Med Sci. 2017;13:864-74.
  • Ansaldo AM, Montecucco F, Sahebkar A, et al. Epicardial adipose tissue and cardiovascular diseases. Int J Cardiol. 2019;278:254-60.
  • Mookadam F, Goel R, Alharthi M, et al. Epicardial fat and its association with cardiovascular risk: A cross-sectional observational study. Heart Views. 2010;11:103-8.
  • Sacks HS, Fain JN. Human epicardial adipose tissue: a review. Am Heart J. 2007;153:907-17.
  • Iacobellis G. Local and systemic effects of the multifaceted epicardial adipose tissue depot. Nat Rev Endocrinol. 2015;11:363.
  • Ueno K, Anzai T, Jinzaki M, et al. Increased Epicardial Fat Volume Quantified by 64-Multidetector Computed Tomography is Associated With Coronary Atherosclerosis and Totally Occlusive Lesions. Circ J. 2009;73:1927-33.
  • Rabkin SW. The relationship between epicardial fat and indices of obesity and the metabolic syndrome: a systematic review and meta-analysis. Metab Syndr Relat Disord. 2014;12:31-42.
  • Liu Z, Li X, Zhang M, et al. The role of Mean Platelet Volume/platelet count Ratio and Neutrophil to Lymphocyte Ratio on the risk of Febrile Seizure. Sci Rep. 2018 Oct 11;8:15123.
  • Skrzypczyk P, Przychodzień J, Bombińska M, et al. Complete blood count-derived inflammatory markers in adolescents with primary arterial hypertension: a preliminary report. Cent Eur J Immunol. 2018;43:434-41.
  • Ghattas A, Griffiths HR, Devitt A, et al.. Monocytes in coronary artery disease and atherosclerosis: where are we now? J Am Coll Cardiol. 2013;62:1541-51.
  • Mergen H, Mergen BE, Tavli TE, et al. Lipoprotein metabolism diseases and approach to their treatment. Turk J Family Med. 2010;14: 38-45.
  • Li Y, Chen S, Shao X, et al. Association of uric acid with metabolic syndrome in men, premenopausal women and postmenopausal women. Int J Environ Res Public Health. 2014;11:2899-910.
  • Çayakar A. Sedimentation & CRP-From Past to Future. Aegean J Med Sci. 2019;2:85-96.
  • Iacobellis G, Willens HJ, Barbaro G, et al. Threshold values of highrisk echocardiographic epicardial fat thickness. Obesity (Silver Spring, Md). 2008;16:887-92.
  • Wang TD, Lee WJ, Shih FY, et al. Relations of epicardial adipose tissue measured by multidetector computed tomography to components of the metabolic syndrome are region-specific and independent of anthropometric indexes and intraabdominal visceral fat. J Clin Endocrinol Metab. 2009;94:662-9.
  • de Vos AM, Prokop M, Roos CJ, et al. Peri-coronary epicardial adipose tissue is related to cardiovascular risk factors and coronary artery calcification in post-menopausal women. Eur Heart J. 2008 Mar;29:777-83.
  • Bertaso AG, Bertol D, Duncan BB, et al. Epicardial fat: definition, measurements and systematic review of main outcomes. Arq Bras Cardiol. 2013;101:18-28.
  • Fox CS, Gona P, Hoffmann U, et al. Pericardial fat, intrathoracic fat, and measures of left ventricular structure and function: the Framingham Heart Study. Circulation. 2009;119:1586-91.
  • Larsen SB, Grove EL, Würtz M, et al. The influence of low-grade inflammation on platelets in patients with stable coronary artery disease. Thromb Haemost. 2015;114:519-29.
  • Ridker PM. From C-Reactive Protein to Interleukin-6 to Interleukin-1: Moving Upstream To Identify Novel Targets for Atheroprotection. Circ Res. 2016;118:145-56.
  • Rom O, Karkabi K, Reznick AZ, et al. Relationship between history of smoking, metabolic and inflammatory markers, parameters of body composition and muscle strength. Adv Exp Med Biol. 2015;849:49-56.
  • Alyan O, Kaçmaz F, Özdemir O, et al. Increased levels of high-sensitivity C-reactive protein and impaired autonomic activity in smokers. Turk Kardiyol Dern Ars. 2008;36:368-75.
  • Ugovšek S, Šebeštjen M. Lipoprotein(a)-The Crossroads of Atherosclerosis, Atherothrombosis and Inflammation. Biomolecules. 2021;24;12:26.
  • Karampetsou N, Tzani A, Doulamis IP, et al. Epicardial Adipocyte-derived TNF-α Modulates Local Inflammation in Patients with Advanced Coronary Artery Disease. Curr Vasc Pharmacol. 2022;20:87-93.
  • Bachar GN, Dicker D, Kornowski R, Atar E. Epicardial adipose tissue as a predictor of coronary artery disease in asymptomatic subjects. Am J Cardiol. 2012;110:534-8.
  • Benowitz NL. Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addiction. N Engl J Med. 1988;319:1318-30.
  • Folts JD, Gering SA, Laibly SW, et al. Effects of cigarette smoke and nicotine on platelets and experimental coronary artery thrombosis. Adv Exp Med Biol. 1990;273:339-58.
  • Cekici Y, Yilmaz M, Secen O. New inflammatory indicators: association of high eosinophil-to-lymphocyte ratio and low lymphocyte-to-monocyte ratio with smoking. The J Int Med Res. 2019;47:4292-303.
  • Freeman DJ, Griffin BA, Murray E, et al. Smoking and plasma lipoproteins in man: effects on low density lipoprotein cholesterol levels and high density lipoprotein subfraction distribution. Eur J Clin Invest. 1993;23:630-40.
  • Abdulnaby NK, Sayed AO, Shalaby NM. Predictive value of serum uric acid in hospitalized adolescents and adults with acute asthma. Ther Clin Risk Manag. 2016;12:1701-8.
  • Kim JA, Chun EJ, Lee MS, et al. Relationship between amount of cigarette smoking and coronary atherosclerosis on coronary CTA in asymptomatic individuals. Int J Cardiovasc Imaging. 2013;29:21-8.
  • Pekmez H, Ogeturk M, Ozyurt H, et al. Ameliorative effect of caffeic acid phenethyl ester on histopathological and biochemical changes induced by cigarette smoke in rat kidney. Toxicol Ind Health. 2010;26:175-82.
  • Centers for Disease C, Prevention, National Center for Chronic Disease P, Health P, Office on S, Health. Publications and Reports of the Surgeon General. How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. Atlanta (GA): Centers for Disease Control and Prevention (US); 2010.
  • Linneberg A, Jacobsen RK, Skaaby T, et al. Effect of Smoking on Blood Pressure and Resting Heart Rate: A Mendelian Randomization MetaAnalysis in the CARTA Consortium. Circ Cardiovasc Genet. 2015;8:832- 41.
APA Soylu Y, çoşkun r, Ozcicek A, Ozcicek F, Mertoglu C, ARSLAN Y (2022). Evaluation of epicardial adipose tissue thickness and inflammatory parameters in smokers and non-smokers. , 1158 - 1165. 10.5455/medscience.2021.11.383
Chicago Soylu Yasin Emrah,çoşkun reşit,Ozcicek Adalet,Ozcicek Fatih,Mertoglu Cuma,ARSLAN YUSUF KEMAL Evaluation of epicardial adipose tissue thickness and inflammatory parameters in smokers and non-smokers. (2022): 1158 - 1165. 10.5455/medscience.2021.11.383
MLA Soylu Yasin Emrah,çoşkun reşit,Ozcicek Adalet,Ozcicek Fatih,Mertoglu Cuma,ARSLAN YUSUF KEMAL Evaluation of epicardial adipose tissue thickness and inflammatory parameters in smokers and non-smokers. , 2022, ss.1158 - 1165. 10.5455/medscience.2021.11.383
AMA Soylu Y,çoşkun r,Ozcicek A,Ozcicek F,Mertoglu C,ARSLAN Y Evaluation of epicardial adipose tissue thickness and inflammatory parameters in smokers and non-smokers. . 2022; 1158 - 1165. 10.5455/medscience.2021.11.383
Vancouver Soylu Y,çoşkun r,Ozcicek A,Ozcicek F,Mertoglu C,ARSLAN Y Evaluation of epicardial adipose tissue thickness and inflammatory parameters in smokers and non-smokers. . 2022; 1158 - 1165. 10.5455/medscience.2021.11.383
IEEE Soylu Y,çoşkun r,Ozcicek A,Ozcicek F,Mertoglu C,ARSLAN Y "Evaluation of epicardial adipose tissue thickness and inflammatory parameters in smokers and non-smokers." , ss.1158 - 1165, 2022. 10.5455/medscience.2021.11.383
ISNAD Soylu, Yasin Emrah vd. "Evaluation of epicardial adipose tissue thickness and inflammatory parameters in smokers and non-smokers". (2022), 1158-1165. https://doi.org/10.5455/medscience.2021.11.383
APA Soylu Y, çoşkun r, Ozcicek A, Ozcicek F, Mertoglu C, ARSLAN Y (2022). Evaluation of epicardial adipose tissue thickness and inflammatory parameters in smokers and non-smokers. Medicine Science, 11(3), 1158 - 1165. 10.5455/medscience.2021.11.383
Chicago Soylu Yasin Emrah,çoşkun reşit,Ozcicek Adalet,Ozcicek Fatih,Mertoglu Cuma,ARSLAN YUSUF KEMAL Evaluation of epicardial adipose tissue thickness and inflammatory parameters in smokers and non-smokers. Medicine Science 11, no.3 (2022): 1158 - 1165. 10.5455/medscience.2021.11.383
MLA Soylu Yasin Emrah,çoşkun reşit,Ozcicek Adalet,Ozcicek Fatih,Mertoglu Cuma,ARSLAN YUSUF KEMAL Evaluation of epicardial adipose tissue thickness and inflammatory parameters in smokers and non-smokers. Medicine Science, vol.11, no.3, 2022, ss.1158 - 1165. 10.5455/medscience.2021.11.383
AMA Soylu Y,çoşkun r,Ozcicek A,Ozcicek F,Mertoglu C,ARSLAN Y Evaluation of epicardial adipose tissue thickness and inflammatory parameters in smokers and non-smokers. Medicine Science. 2022; 11(3): 1158 - 1165. 10.5455/medscience.2021.11.383
Vancouver Soylu Y,çoşkun r,Ozcicek A,Ozcicek F,Mertoglu C,ARSLAN Y Evaluation of epicardial adipose tissue thickness and inflammatory parameters in smokers and non-smokers. Medicine Science. 2022; 11(3): 1158 - 1165. 10.5455/medscience.2021.11.383
IEEE Soylu Y,çoşkun r,Ozcicek A,Ozcicek F,Mertoglu C,ARSLAN Y "Evaluation of epicardial adipose tissue thickness and inflammatory parameters in smokers and non-smokers." Medicine Science, 11, ss.1158 - 1165, 2022. 10.5455/medscience.2021.11.383
ISNAD Soylu, Yasin Emrah vd. "Evaluation of epicardial adipose tissue thickness and inflammatory parameters in smokers and non-smokers". Medicine Science 11/3 (2022), 1158-1165. https://doi.org/10.5455/medscience.2021.11.383